<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Cardinal Health Inc — News on 6ix</title>
<link>https://6ix.com/company/cardinal-health-inc</link>
<description>Latest news and press releases for Cardinal Health Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 14 Apr 2026 11:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/cardinal-health-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683551c078dffbe2df0e7c0e.webp</url>
<title>Cardinal Health Inc</title>
<link>https://6ix.com/company/cardinal-health-inc</link>
</image>
<item>
<title>Cardinal Health report highlights growing momentum to expand advanced therapies into community care settings</title>
<link>https://6ix.com/company/cardinal-health-inc/news/cardinal-health-report-highlights-growing-momentum-to-expand-advanced-therapies-into-community-care-settings</link>
<guid isPermaLink="true">https://6ix.com/company/cardinal-health-inc/news/cardinal-health-report-highlights-growing-momentum-to-expand-advanced-therapies-into-community-care-settings</guid>
<pubDate>Tue, 14 Apr 2026 11:00:00 GMT</pubDate>
<description>Today, Cardinal Health (NYSE: CAH) released its 2026 Advanced Therapies Report: Perspectives on Community Expansion, offering new insights into how the expanding advanced therapy pipeline is reshaping sites of care. Advanced therapies are innovative gene-, cell- and tissue-based treatments that target the root cause of disease by repairing, replacing or regenerating damaged cells, offering long-term benefits for many conditions. As more therapies shift to outpatient and community-based settings,</description>
</item>
<item>
<title>Outset Medical Names Derick Elliott as Executive Vice President of Commercial</title>
<link>https://6ix.com/company/cardinal-health-inc/news/outset-medical-names-derick-elliott-as-executive-vice-president-of-commercial-1</link>
<guid isPermaLink="true">https://6ix.com/company/cardinal-health-inc/news/outset-medical-names-derick-elliott-as-executive-vice-president-of-commercial-1</guid>
<pubDate>Mon, 06 Apr 2026 20:05:00 GMT</pubDate>
<description>SAN JOSE, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today announced the appointment of Derick Elliott as Executive Vice President of Commercial, effective immediately. Mr. Elliott is responsible for Outset’s commercial organizations supporting acute, post-acute and home healthcare providers, reporting to Chair and CEO L</description>
</item>
<item>
<title>Cardinal Health expands Actinium-225 production capacity to support growing demand for novel cancer therapies</title>
<link>https://6ix.com/company/cardinal-health-inc/news/cardinal-health-expands-actinium-225-production-capacity-to-support-growing-demand-for-novel-cancer-therapies</link>
<guid isPermaLink="true">https://6ix.com/company/cardinal-health-inc/news/cardinal-health-expands-actinium-225-production-capacity-to-support-growing-demand-for-novel-cancer-therapies</guid>
<pubDate>Wed, 01 Apr 2026 11:00:00 GMT</pubDate>
<description>Cardinal Health (NYSE:CAH) today announced a significant expansion of its Actinium-225 (Ac-225) production capabilities at the company's Center for Theranostics Advancement (CTA) in Indianapolis, Indiana. The addition of a high-capacity production line to its Drug Master File (DMF) will substantially increase Cardinal Health's supply of cGMP-compliant Ac-225 for use in investigational therapeutic drug products and future commercial manufacturing novel therapies.</description>
</item>
<item>
<title>Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2026 on April 30</title>
<link>https://6ix.com/company/cardinal-health-inc/news/cardinal-health-to-announce-third-quarter-results-for-fiscal-year-2026-on-april-30</link>
<guid isPermaLink="true">https://6ix.com/company/cardinal-health-inc/news/cardinal-health-to-announce-third-quarter-results-for-fiscal-year-2026-on-april-30</guid>
<pubDate>Tue, 24 Mar 2026 10:45:00 GMT</pubDate>
<description>Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2026 on April 30 as previously indicated, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.</description>
</item>
<item>
<title>Cardinal Health Appoints Patricia A. Hemingway Hall as Board Chair</title>
<link>https://6ix.com/company/cardinal-health-inc/news/cardinal-health-appoints-patricia-a-hemingway-hall-as-board-chair</link>
<guid isPermaLink="true">https://6ix.com/company/cardinal-health-inc/news/cardinal-health-appoints-patricia-a-hemingway-hall-as-board-chair</guid>
<pubDate>Mon, 23 Mar 2026 10:45:00 GMT</pubDate>
<description>Cardinal Health (NYSE: CAH) today announced that its Board of Directors has appointed Patricia A. Hemingway Hall to succeed Gregory B. Kenny as Chair of the Board following Mr. Kenny's retirement, effective immediately.</description>
</item>
<item>
<title>Carecubes Closes $6.5 Million Series A to Transform Infectious Disease Response</title>
<link>https://6ix.com/company/cardinal-health-inc/news/carecubes-closes-dollar65-million-series-a-to-transform-infectious-disease-response</link>
<guid isPermaLink="true">https://6ix.com/company/cardinal-health-inc/news/carecubes-closes-dollar65-million-series-a-to-transform-infectious-disease-response</guid>
<pubDate>Thu, 19 Mar 2026 11:30:00 GMT</pubDate>
<description>Carecubes, which is transforming infectious disease response through its FDA 510(k)-cleared isolation unit—built for rapid deployment wherever care is needed—today announced the close of its $6.5 million Series A funding round, with backing from prominent leaders in healthcare and the public sector.</description>
</item>
<item>
<title>Cardinal Health report highlights cost savings and provider confidence in biosimilars</title>
<link>https://6ix.com/company/cardinal-health-inc/news/cardinal-health-report-highlights-cost-savings-and-provider-confidence-in-biosimilars</link>
<guid isPermaLink="true">https://6ix.com/company/cardinal-health-inc/news/cardinal-health-report-highlights-cost-savings-and-provider-confidence-in-biosimilars</guid>
<pubDate>Tue, 24 Feb 2026 12:00:00 GMT</pubDate>
<description>Cardinal Health (NYSE: CAH) today released its 2026 Biosimilars Report: Driving access and patient outcomes in physician practices, which highlights the substantial savings biosimilars have delivered to the U.S. healthcare system and the strong confidence providers have in these treatments.</description>
</item>
<item>
<title>Cardinal Health Reports Second Quarter Fiscal Year 2026 Results and Raises Outlook</title>
<link>https://6ix.com/company/cardinal-health-inc/news/cardinal-health-reports-second-quarter-114500315</link>
<guid isPermaLink="true">https://6ix.com/company/cardinal-health-inc/news/cardinal-health-reports-second-quarter-114500315</guid>
<pubDate>Thu, 05 Feb 2026 11:45:00 GMT</pubDate>
<description>Cardinal Health (NYSE: CAH) today reported second quarter fiscal year 2026 revenues of $65.6 billion, an increase of 19% from the second quarter of fiscal year 2025. Second quarter GAAP operating earnings increased 29% to $707 million and GAAP diluted earnings per share (EPS) increased 19% to $1.97. Second quarter non-GAAP operating earnings increased 38% to $877 million. Non-GAAP diluted EPS increased 36% to $2.63, reflecting the increase in non-GAAP operating earnings and a lower share count,</description>
</item>
<item>
<title>Cardinal Health Raises Fiscal 2026 Outlook and Highlights Strategic Progress During J.P. Morgan Healthcare Conference Presentation</title>
<link>https://6ix.com/company/cardinal-health-inc/news/cardinal-health-raises-fiscal-2026-115000856</link>
<guid isPermaLink="true">https://6ix.com/company/cardinal-health-inc/news/cardinal-health-raises-fiscal-2026-115000856</guid>
<pubDate>Tue, 13 Jan 2026 11:50:00 GMT</pubDate>
<description>Cardinal Health (NYSE:CAH) today provided an update to its financial outlook for fiscal year 2026 and plans to highlight significant progress with its strategic growth initiatives during the 44th Annual J.P. Morgan Healthcare Conference.</description>
</item>
<item>
<title>Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2026 on February 5</title>
<link>https://6ix.com/company/cardinal-health-inc/news/cardinal-health-announce-second-quarter-114500822</link>
<guid isPermaLink="true">https://6ix.com/company/cardinal-health-inc/news/cardinal-health-announce-second-quarter-114500822</guid>
<pubDate>Tue, 06 Jan 2026 11:45:00 GMT</pubDate>
<description>Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2026 on February 5, prior to the opening of trading on the ...</description>
</item>
<item>
<title>TempraMed Announces Strategic Agreement with Maccabi Healthcare Services, a Leading HMO with over 2.8 Million Patients</title>
<link>https://6ix.com/company/cardinal-health-inc/news/tempramed-announces-strategic-agreement-with-maccabi-healthcare-services-a-leading-hmo-with-over-28-million-patients</link>
<guid isPermaLink="true">https://6ix.com/company/cardinal-health-inc/news/tempramed-announces-strategic-agreement-with-maccabi-healthcare-services-a-leading-hmo-with-over-28-million-patients</guid>
<pubDate>Mon, 08 Dec 2025 22:00:00 GMT</pubDate>
<description>Vancouver, British Columbia--(Newsfile Corp. - December 8, 2025) - TempraMed Technologies Ltd. (CSE: VIVI) ("TempraMed" or the "Company"), a medical technology innovator transforming how temperature-sensitive medications are stored and managed, is pleased to announce a major commercial milestone as part of its broader global expansion strategy: its flagship products, the VIVI Cap and VIVI EPI, are now available through Maccabi Healthcare Services, Israel's second-largest health maintenance...</description>
</item>
<item>
<title>OnPoint Surgical, Inc. Appoints Jeremy Laynor as Chief Commercial Officer to Accelerate Global Growth</title>
<link>https://6ix.com/company/cardinal-health-inc/news/onpoint-surgical-inc-appoints-jeremy-laynor-as-chief-commercial-officer-to-accelerate-global-growth</link>
<guid isPermaLink="true">https://6ix.com/company/cardinal-health-inc/news/onpoint-surgical-inc-appoints-jeremy-laynor-as-chief-commercial-officer-to-accelerate-global-growth</guid>
<pubDate>Wed, 12 Nov 2025 19:07:00 GMT</pubDate>
<description>OnPoint Surgical, Inc., a leader in Augmented Reality (AR) and Artificial Intelligence (AI) guidance for spinal interventions, today announced the appointment of Jeremy Laynor as Chief Commercial Officer (CCO).</description>
</item>
<item>
<title>Cardinal Health Board of Directors Approves Quarterly Dividend</title>
<link>https://6ix.com/company/cardinal-health-inc/news/cardinal-health-board-directors-approves-214500747</link>
<guid isPermaLink="true">https://6ix.com/company/cardinal-health-inc/news/cardinal-health-board-directors-approves-214500747</guid>
<pubDate>Tue, 04 Nov 2025 21:45:00 GMT</pubDate>
<description>Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5107 per share, out of the Company's capital surplus. The dividend will be payable on January 15, 2026 to shareholders of record at the close of business on January 2, 2026.</description>
</item>
<item>
<title>Cardinal Health completes acquisition of Solaris Health</title>
<link>https://6ix.com/company/cardinal-health-inc/news/cardinal-health-completes-acquisition-solaris-133000477</link>
<guid isPermaLink="true">https://6ix.com/company/cardinal-health-inc/news/cardinal-health-completes-acquisition-solaris-133000477</guid>
<pubDate>Mon, 03 Nov 2025 13:30:00 GMT</pubDate>
<description>Cardinal Health (NYSE: CAH) announced today that it has completed its acquisition of Solaris Health, the country's leading urology MSO. Solaris Health brings more than 750 providers across more than 250 practice locations in 14 states and adds immediate scale to the Urology Alliance within Cardinal Health's leading multi-specialty MSO platform, The Specialty Alliance.</description>
</item>
<item>
<title>Cardinal Health Reports First Quarter Fiscal Year 2026 Results and Raises Outlook</title>
<link>https://6ix.com/company/cardinal-health-inc/news/cardinal-health-reports-first-quarter-104500312</link>
<guid isPermaLink="true">https://6ix.com/company/cardinal-health-inc/news/cardinal-health-reports-first-quarter-104500312</guid>
<pubDate>Thu, 30 Oct 2025 10:45:00 GMT</pubDate>
<description>Cardinal Health (NYSE: CAH) today reported first quarter fiscal year 2026 revenues of $64 billion, an increase of 22% from the first quarter of fiscal year 2025. First quarter GAAP operating earnings increased 18% to $668 million and GAAP diluted earnings per share (EPS) increased 11% to $1.88. First quarter non-GAAP operating earnings increased 37% to $857 million, driven by segment profit growth across all five of the company's operating segments. Non-GAAP diluted EPS increased 36% to $2.55, r</description>
</item>
<item>
<title>Cycle Pharmaceuticals Launches Its First Oncology Product, PHYRAGO™ (dasatinib) Tablets, in the US</title>
<link>https://6ix.com/company/cardinal-health-inc/news/cycle-pharmaceuticals-launches-its-first-oncology-product-phyragotm-dasatinib-tablets-in-the-us-1</link>
<guid isPermaLink="true">https://6ix.com/company/cardinal-health-inc/news/cycle-pharmaceuticals-launches-its-first-oncology-product-phyragotm-dasatinib-tablets-in-the-us-1</guid>
<pubDate>Thu, 16 Oct 2025 13:00:00 GMT</pubDate>
<description>DETROIT, October 16, 2025--Cycle Pharmaceuticals announces the launch of PHYRAGO, its first oncology product in the US. PHYRAGO is launched in partnership with Handa Therapeutics, LLC, and will be exclusively available through specialty pharmacy Onco360® with a specialty distribution network from McKesson, Cencora, and Cardinal Health.</description>
</item>
<item>
<title>Cardinal Health to expand pharmaceutical distribution network with new Indianapolis facility</title>
<link>https://6ix.com/company/cardinal-health-inc/news/cardinal-health-expand-pharmaceutical-distribution-130700538</link>
<guid isPermaLink="true">https://6ix.com/company/cardinal-health-inc/news/cardinal-health-expand-pharmaceutical-distribution-130700538</guid>
<pubDate>Tue, 30 Sep 2025 13:07:00 GMT</pubDate>
<description>Cardinal Health (NYSE: CAH) today announced plans for a new flagship forward distribution center in Indianapolis, Indiana that will further expand and modernize its national pharmaceutical distribution network. The state-of-the-art forward distribution center will feature automation and the latest technology advancements in support of the segment's distribution of more than 70,000 pharmaceutical and specialty deliveries daily across the United States.</description>
</item>
<item>
<title>Cardinal Health to Announce First-Quarter Results for Fiscal Year 2026 on October 30</title>
<link>https://6ix.com/company/cardinal-health-inc/news/cardinal-health-announce-first-quarter-104500812</link>
<guid isPermaLink="true">https://6ix.com/company/cardinal-health-inc/news/cardinal-health-announce-first-quarter-104500812</guid>
<pubDate>Tue, 23 Sep 2025 10:45:00 GMT</pubDate>
<description>Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2026 on October 30, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.</description>
</item>
<item>
<title>Cardinal Health Unveils State-of-the-Art Consumer Health Logistics Center</title>
<link>https://6ix.com/company/cardinal-health-inc/news/cardinal-health-unveils-state-art-160000022</link>
<guid isPermaLink="true">https://6ix.com/company/cardinal-health-inc/news/cardinal-health-unveils-state-art-160000022</guid>
<pubDate>Mon, 15 Sep 2025 16:00:00 GMT</pubDate>
<description>Cardinal Health (NYSE: CAH) today is showcasing its newly operational Consumer Health Logistics Center, a 350,000-square-foot facility in Groveport, Ohio. Purpose-built as a centralized replenishment hub, this facility serves as a vital link in the company's supply chain, efficiently distributing over-the-counter medications, treatments, and diagnostic solutions to a network of more than 20 forward distribution centers serving customers nationwide.</description>
</item>
<item>
<title>Cardinal Health at-Home Solutions opens Texas distribution center; announces plans for new California site</title>
<link>https://6ix.com/company/cardinal-health-inc/news/cardinal-health-home-solutions-opens-154000929</link>
<guid isPermaLink="true">https://6ix.com/company/cardinal-health-inc/news/cardinal-health-home-solutions-opens-154000929</guid>
<pubDate>Thu, 04 Sep 2025 15:40:00 GMT</pubDate>
<description>Cardinal Health (NYSE: CAH) announced the opening of its newest distribution center in Fort Worth, Texas – a facility solely dedicated to the at-Home Solutions business, a leading medical supplies provider that serves more than 6 million people annually in the United States. In addition, Cardinal Health announced that it will also break ground on a new distribution center dedicated to at-Home Solutions in Sacramento, California, this fiscal year.</description>
</item>
</channel>
</rss>